Vanda Pharmaceuticals Ownership | Who Owns Vanda Pharmaceuticals?
Vanda Pharmaceuticals Ownership Summary
Vanda Pharmaceuticals is owned by 84.63% institutional investors, 6.61% insiders, and 8.76% retail investors. Blackrock is the largest institutional shareholder, holding 14.09% of VNDA shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.73% of its assets in Vanda Pharmaceuticals shares.
VNDA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Vanda Pharmaceuticals | 84.63% | 6.61% | 8.76% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 8.14M | 14.09% | $45.98M |
| Blackrock funding, inc. /de | 7.65M | 12.87% | $46.84M |
| Vanguard group | 3.73M | 6.34% | $32.91M |
| State street | 3.52M | 5.91% | $21.52M |
| Aqr capital management | 3.50M | 5.88% | $21.41M |
| Renaissance | 3.44M | 5.79% | $21.06M |
| Vanguard capital management | 2.52M | 4.24% | $15.45M |
| Tang capital management | 2.35M | 3.99% | $11.74M |
| Aigh capital management | 2.04M | 3.44% | $12.51M |
| Acadian asset management | 1.92M | 3.23% | $11.73M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Krensavage asset management | 1.18M | 2.74% | $7.22M |
| Aigh capital management | 2.04M | 0.79% | $12.51M |
| Tang capital management | 2.35M | 0.45% | $11.74M |
| Pharvision advisers | 57.04K | 0.16% | $284.62K |
| Monaco asset management sam | 221.29K | 0.11% | $1.35M |
| Diker management | 21.88K | 0.10% | $134.00K |
| One68 global capital | 26.06K | 0.06% | $119.61K |
| Y-intercept (hong kong) | 294.13K | 0.04% | $1.80M |
| Inscription capital | 63.88K | 0.03% | $390.93K |
| Renaissance | 3.44M | 0.03% | $21.06M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Aqr capital management | 3.50M | 0.01% | 1.89M |
| Qube research | 729.21K | 0.00% | 729.21K |
| Sixth street partners management company | 646.26K | 0.00% | 646.26K |
| Marshall wace, llp | 1.23M | 0.01% | 629.99K |
| State street | 3.52M | 0.00% | 500.84K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Nantahala capital management | - | - | -1.59M |
| Empire financial management company | - | - | -922.25K |
| Assenagon asset management | - | - | -730.82K |
| Aigh capital management | 2.04M | 0.79% | -705.83K |
| Apg asset management | - | - | -371.90K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sixth street partners management company | 646.26K | 0.00% | 646.26K | $3.96M |
| Y-intercept (hong kong) | 294.13K | 0.04% | 294.13K | $1.80M |
| Norges bank | 115.00K | 0.00% | 115.00K | $550.85K |
| Cubist systematic strategies | 63.82K | 0.00% | 63.82K | $318.47K |
| Pharvision advisers | 57.04K | 0.16% | 57.04K | $284.62K |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -2.00 |
| Twin peaks wealth advisors | -3.00 |
| Nelson, van denburg & campbell wealth management group | -10.00 |
| Advisory services network | -21.00 |
| Gps wealth strategies group | -25.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 175 | - | 50,320,080 | 8.86% | 84 | 1.38% | 96 | -14.29% | 55 | 41.03% |
| Mar 31, 2026 | 168 | 4.35% | 45,092,027 | 7.65% | 76 | 1.52% | 107 | 52.86% | 38 | -39.68% |
| Dec 31, 2025 | 38 | -75.64% | 6,341,924 | -85.88% | 10 | 0.19% | 17 | -76.06% | 12 | -77.36% |
| Sep 30, 2025 | 51 | -64.34% | 6,811,734 | -84.86% | 11 | 0.20% | 22 | -67.65% | 15 | -67.39% |
| Jun 30, 2025 | 142 | -7.79% | 44,993,385 | 2.43% | 76 | 1.35% | 67 | 3.08% | 46 | -16.36% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 2.26M | 3.73% | 5.18K |
| Vanguard US Total Market Shares ETF | 1.74M | 2.99% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.76M | 2.93% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.76M | 2.93% | - |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.76M | 2.91% | - |
| iShares Russell 2000 ETF | 1.37M | 2.27% | -24.38K |
| BlackRock Advantage Small Cap Core Instl | 746.59K | 1.23% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 705.33K | 1.17% | 1.85K |
| Fidelity Small Cap Index | 561.82K | 0.93% | 9.98K |
| Nuveen Quant Small Cap Equity R6 | 530.50K | 0.91% | 166.10K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 02, 2026 | Williams Timothy | SVP & General Counsel | Sell | $350.76K |
| Mar 02, 2026 | Moran Kevin Patrick | SVP, CFO & Treasurer | Sell | $350.82K |
| Mar 02, 2026 | Wijkstrom Joakim | SVP, Chief Marketing Officer | Sell | $254.59K |
| Mar 02, 2026 | Polymeropoulos Mihael Hristos | President and CEO | Sell | $1.28M |
| Mar 02, 2026 | Birznieks Gunther | SVP, Business Development | Sell | $350.73K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | 6 |
| 2025 Q3 | 1 | - |
| 2025 Q2 | 3 | 1 |
| 2025 Q1 | 11 | - |
VNDA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools